Preferred Label : Formoterol Fumarate;
MeSH definition : An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used
to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.;
MeSH synonym : Formoterol Fumarate, ((R*,R*)-( -))-isomer; 3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate;
MeSH hyponym : oxis; formoterol; foradil; BD 40A; arformoterol; Eformoterol; Formoterol, ((R*,R*)-( -))-isomer;
MeSH Related Number : 43229-80-7 (formoterol fumarate); 5ZZ84GCW8B; F91H02EBWT;
Wikipedia link : https://en.wikipedia.org/wiki/Eformoterol;
Is substance : O;
UNII : W34SHF8J2K;
Origin ID : D000068759;
UMLS CUI : C0771469;
ATC code(s)
- ATC code(s)
- Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- Exact mapping(s) to DCI
- Pharmacological action(s)
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- See also
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
- Validated automatic mappings to NTBT
An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used
to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
https://www.has-sante.fr/jcms/p_3599701/fr/beclometasone-formoterol-biogaran-beclometasone-/-formoterol-asthme-bronchopneumopathie-chronique-obstructive-bpco
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, inhalation
formoterol and beclometasone
evaluation of the transparency committee
asthma
beclomethasone
pulmonary disease, chronic obstructive
Formoterol Fumarate
---
https://www.has-sante.fr/jcms/p_3390009/fr/trimbow-dipropionate-de-beclometasone-fumarate-de-formoterol-dihydrate-glycopyrronium-bronchopneumopathie-chronique-obstructive
2022
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
glycopyrrolate
administration, inhalation
formoterol, glycopyrronium bromide and beclometasone
evaluation of the transparency committee
Formoterol Fumarate
pulmonary disease, chronic obstructive
Beclomethasone Dipropionate
beclomethasone
---
https://www.has-sante.fr/jcms/p_3242546/
2021
false
false
false
France
drug combinations
insurance, health, reimbursement
treatment outcome
formoterol, glycopyrronium bromide and budesonide
administration, inhalation
guidelines for drug use
pulmonary disease, chronic obstructive
adult
glycopyrrolate
Formoterol Fumarate
budesonide
bronchodilator agents
glucocorticoids
adrenergic beta-2 receptor agonists
muscarinic antagonists
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3281234/fr/trimbow-formoterol/-bromure-de-glycopyrronium/-beclometasone-asthme
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
administration, inhalation
beclomethasone
Beclomethasone Dipropionate
Formoterol Fumarate
Glycopyrronium
asthma
adult
adrenergic beta-2 receptor agonists
muscarinic antagonists
bronchodilator agents
glucocorticoids
formoterol, glycopyrronium bromide and beclometasone
evaluation of the transparency committee
---
https://www.cochrane.org/fr/CD007694/AIRWAYS_les-personnes-asthmatiques-ont-elles-moins-deffets-indesirables-graves-lorsquelles-prennent-du
2021
false
true
false
United Kingdom
France
Asthma chronic
corticosteroid therapy
adrenal cortex hormones
Formoterol Fumarate
Salmeterol Xinafoate
treatment outcome
review of literature
french abstract
asthma
administration, inhalation
adrenal cortex hormones
---
https://www.ema.europa.eu/en/medicines/human/EPAR/trixeo-aerosphere
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
budesonide
budesonide
glucocorticoids
glucocorticoids
bronchodilator agents
bronchodilator agents
formoterol, glycopyrronium bromide and budesonide
formoterol
formoterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
adult
administration, inhalation
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Formoterol Fumarate
Formoterol Fumarate
glycopyrrolate
glycopyrrolate
---
https://www.has-sante.fr/jcms/p_3192402/fr/duaklir-genuair
2020
false
false
false
France
drug combinations
formoterol and aclidinium bromide
insurance, health, reimbursement
treatment outcome
administration, inhalation
aclidinium bromide
muscarinic antagonists
Formoterol Fumarate
adrenergic beta-2 receptor agonists
bronchodilator agents
adult
pulmonary disease, chronic obstructive
Product containing only aclidinium and formoterol in pulmonary dose form (medicinal
product form)
evaluation of the transparency committee
tropanes
---
https://www.has-sante.fr/jcms/p_3178573/fr/innovair-nexthaler-formodual-nexthaler
2020
false
false
false
France
Beclomethasone Dipropionate
Formoterol Fumarate
drug combinations
evaluation of the transparency committee
beclomethasone
---
https://www.has-sante.fr/jcms/p_3168747/fr/trydonis
2020
false
false
false
France
drug combinations
treatment outcome
muscarinic antagonists
Beclomethasone Dipropionate
glucocorticoids
Formoterol Fumarate
adrenergic beta-2 receptor agonists
bronchodilator agents
formoterol, glycopyrronium bromide and beclometasone
insurance, health, reimbursement
adult
pulmonary disease, chronic obstructive
evaluation of the transparency committee
glycopyrrolate
beclomethasone
---
https://www.has-sante.fr/jcms/p_3165670/fr/trimbow
2020
false
false
false
France
formoterol, glycopyrronium bromide and beclometasone
pulmonary disease, chronic obstructive
Beclomethasone Dipropionate
administration, inhalation
Formoterol Fumarate
glycopyrrolate
adrenergic beta-2 receptor agonists
muscarinic antagonists
bronchodilator agents
anti-inflammatory agents
drug combinations
glucocorticoids
drug prescriptions
insurance, health, reimbursement
evaluation of the transparency committee
beclomethasone
---
https://www.has-sante.fr/jcms/p_3109940/fr/trimbow
2020
false
false
false
France
French
administration, inhalation
treatment outcome
insurance, health, reimbursement
adult
drug combinations
pulmonary disease, chronic obstructive
bronchodilator agents
glucocorticoids
adrenergic beta-2 receptor agonists
muscarinic antagonists
Beclomethasone Dipropionate
Formoterol Fumarate
glycopyrrolate
formoterol, glycopyrronium bromide and beclometasone
beclomethasone
---
https://www.cochrane.org/fr/CD006924/traitement-regulier-au-formoterol-et-aux-steroides-inhales-pour-lasthme-chronique-effets
2019
false
true
false
France
United Kingdom
Asthma chronic
Formoterol Fumarate
Formoterol Fumarate
adrenal cortex hormones
adrenal cortex hormones
treatment outcome
review of literature
french abstract
administration, inhalation
asthma
---
https://www.has-sante.fr/jcms/p_3135583/fr/trydonis
2019
false
false
false
France
French
evaluation of the transparency committee
drug combinations
treatment outcome
insurance, health, reimbursement
adult
formoterol, glycopyrronium bromide and beclometasone
administration, inhalation
Beclomethasone Dipropionate
pulmonary disease, chronic obstructive
glucocorticoids
Formoterol Fumarate
adrenergic beta-2 receptor agonists
bronchodilator agents
muscarinic antagonists
beclomethasone
glycopyrrolate
---
https://www.has-sante.fr/jcms/p_3109929/fr/trimbow
2019
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, inhalation
pulmonary disease, chronic obstructive
drug combinations
formoterol, glycopyrronium bromide and beclometasone
Beclomethasone Dipropionate
Formoterol Fumarate
glycopyrrolate
adrenergic beta-2 receptor agonists
bronchodilator agents
muscarinic antagonists
glucocorticoids
adult
evaluation of the transparency committee
beclomethasone
---
https://www.ema.europa.eu/en/medicines/human/EPAR/bevespi-aerosphere
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
glycopyrrolate
glycopyrrolate
muscarinic antagonists
muscarinic antagonists
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Formoterol Fumarate
Formoterol Fumarate
bronchodilator agents
bronchodilator agents
pulmonary disease, chronic obstructive
administration, inhalation
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
formoterol and glycopyrronium bromide
---
Trydonis - beclometasone / formoterol / glycopyrronium bromide
https://www.ema.europa.eu/medicines/human/EPAR/Trydonis
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
drug interactions
pregnancy
breast feeding
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
forced expiratory volume
drug evaluation, preclinical
formoterol, glycopyrronium bromide and beclometasone
drug evaluation
glycopyrrolate
beclomethasone
Formoterol Fumarate
---
Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) - beclometasone / formoterol
/ glycopyrronium bromide
https://www.ema.europa.eu/medicines/human/EPAR/riarify-previously-chf-5993-chiesi-farmaceutici-spa
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
drug interactions
pregnancy
breast feeding
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
forced expiratory volume
drug evaluation, preclinical
formoterol, glycopyrronium bromide and beclometasone
drug evaluation
glycopyrrolate
beclomethasone
Formoterol Fumarate
---
https://www.has-sante.fr/portail/jcms/c_2842287/fr/trimbow
https://www.has-sante.fr/portail/jcms/c_2842287/fr/trimbow-beclometasone-/-formoterol-/-glycopyrronium-association-corticoide-inhale-csi-bronchodilatateur-beta-2-agoniste-de-longue-duree-d-action-laba-et-bronchodilatateur-anticholinergique-de-longue-duree-d-action-lama
2018
false
false
false
false
France
French
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
formoterol, glycopyrronium bromide and beclometasone
insurance, health, reimbursement
evaluation of the transparency committee
guidelines for drug use
glycopyrrolate
beclomethasone
Formoterol Fumarate
---
https://www.has-sante.fr/portail/jcms/c_2886947/fr/affera-flutiform
2018
false
true
false
France
Fluticasone Propionate
Formoterol Fumarate
adolescent
adult
asthma
administration, inhalation
formoterol and fluticasone
adrenergic beta-2 receptor agonists
anti-inflammatory agents
bronchodilator agents
evaluation of the transparency committee
fluticasone-formoterol
androstadienes
drug combinations
ethanolamines
Fluticasone
---
https://www.has-sante.fr/portail/jcms/c_2898717/fr/trydonis
2018
false
false
false
France
French
drug combinations
treatment outcome
Beclomethasone Dipropionate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
aged
adrenergic beta-2 receptor agonists
bronchodilator agents
anti-inflammatory agents
muscarinic antagonists
formoterol, glycopyrronium bromide and beclometasone
glycopyrrolate
beclomethasone
Formoterol Fumarate
---
https://www.ema.europa.eu/medicines/human/EPAR/Trimbow
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
drug interactions
pregnancy
breast feeding
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
forced expiratory volume
drug evaluation, preclinical
formoterol, glycopyrronium bromide and beclometasone
glycopyrrolate
beclomethasone
Formoterol Fumarate
---
http://www.has-sante.fr/portail/jcms/c_2746343/fr/asmelor-novolizer
2017
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
Formoterol Fumarate
formoterol
---
https://minerva-ebp.be/FR/Article/2115
2017
false
false
false
false
Belgium
French
critical appraisal or critical reading
drug combinations
pulmonary disease, chronic obstructive
treatment outcome
administration, inhalation
glycopyrrolate
Formoterol Fumarate
bronchodilator agents
glucocorticoids
beclomethasone
disease exacerbation
pulmonary disease, chronic obstructive
forced expiratory volume
muscarinic antagonists
comparative effectiveness research
---
http://www.has-sante.fr/portail/jcms/c_2621483/fr/brimica-genuair
2016
false
France
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Formoterol Fumarate
Formoterol Fumarate
evaluation of the transparency committee
insurance, health, reimbursement
formoterol and aclidinium bromide
tropanes
tropanes
administration, inhalation
adult
bronchodilator agents
bronchodilator agents
treatment outcome
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
---
http://www.has-sante.fr/portail/jcms/c_2629899/fr/innovair-formodual-nexthaler
2016
false
France
French
formoterol and beclometasone
Adrenocortical steroid therapy
corticosteroid therapy
Formoterol Fumarate
persistent asthma
evaluation of the transparency committee
drug combinations
administration, inhalation
insurance, health, reimbursement
adrenergic beta-2 receptor agonists
anti-inflammatory agents
beclomethasone
Beclomethasone Dipropionate
bronchodilator agents
glucocorticoids
asthma
---
http://www.has-sante.fr/portail/jcms/c_2630429/fr/quelle-place-pour-les-associations-fixes-corticoide-/-beta-2-mimetique-de-longue-duree-d-action-dans-le-traitement-de-la-bronchopneumopathie-chronique-obstructive
2016
false
false
false
France
French
guidelines for drug use
pulmonary disease, chronic obstructive
drug combinations
formoterol and beclometasone
formoterol and budesonide
Budesonide, Formoterol Fumarate Drug Combination
administration, inhalation
Formoterol Fumarate
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
salmeterol and fluticasone
vilanterol and fluticasone furoate
Fluticasone
vilanterol
beclomethasone
glucocorticoids
adrenergic beta-2 receptor agonists
treatment outcome
benzyl alcohols
chlorobenzenes
---
http://www.has-sante.fr/portail/jcms/c_2598129/fr/formoterol-mylan
2016
false
false
false
false
France
French
evaluation of the transparency committee
Eformoterol fumarate dihydrate 12micrograms breath-actuated dry powder inhaler (product)
corticosteroid therapy
Formoterol Fumarate
---
http://www.has-sante.fr/portail/jcms/c_2612655/fr/innovair-formodual-nexthaler
2016
false
false
false
false
France
French
evaluation of the transparency committee
administration, inhalation
insurance, health, reimbursement
treatment outcome
drug combinations
Beclomethasone Dipropionate
bronchodilator agents
glucocorticoids
pulmonary disease, chronic obstructive
formoterol and beclometasone
adrenergic beta-2 receptor agonists
Formoterol Fumarate
beclomethasone
---
http://www.has-sante.fr/portail/jcms/c_2621462/fr/duaklir-genuair
2016
false
France
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
Formoterol Fumarate
formoterol and aclidinium bromide
insurance, health, reimbursement
evaluation of the transparency committee
tropanes
tropanes
administration, inhalation
adult
bronchodilator agents
treatment outcome
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
---
https://www.ema.europa.eu/medicines/human/EPAR/Duaklir-Genuair
2014
false
United Kingdom
English
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Formoterol Fumarate
Formoterol Fumarate
formoterol and aclidinium bromide
tropanes
tropanes
administration, inhalation
adult
breast feeding
bronchodilator agents
bronchodilator agents
drug interactions
drug evaluation, preclinical
fertility
pregnancy
treatment outcome
drug approval
clinical trials, phase iii as topic
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
drug evaluation
syndication feed
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_1747531/fr/formodual-innovair
http://www.has-sante.fr/portail/jcms/c_1615059/fr/innovair-formodual
2014
false
France
French
formoterol and beclometasone
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Formoterol Fumarate
evaluation of the transparency committee
drug combinations
administration, inhalation
insurance, health, reimbursement
adrenergic beta-2 receptor agonists
anti-inflammatory agents
beclomethasone
Beclomethasone Dipropionate
bronchodilator agents
glucocorticoids
asthma
adult
child
adolescent
randomized controlled trials as topic
ethanolamines
---
https://www.ema.europa.eu/medicines/human/EPAR/Brimica-Genuair
2014
false
United Kingdom
English
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Formoterol Fumarate
Formoterol Fumarate
formoterol and aclidinium bromide
tropanes
tropanes
administration, inhalation
adult
breast feeding
bronchodilator agents
bronchodilator agents
drug interactions
drug evaluation, preclinical
fertility
pregnancy
treatment outcome
drug approval
clinical trials, phase iii as topic
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
drug evaluation
syndication feed
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_1623648/fr/flutiform-iffeza-affera
http://www.has-sante.fr/portail/jcms/c_1623647/fr/flutiform-iffeza-affera-26062013-avis-ct12574
2013
false
France
French
formoterol and fluticasone
corticosteroid therapy
Fluticasone
Formoterol Fumarate
Fluticasone Propionate
evaluation of the transparency committee
drug combinations
administration, inhalation
adrenergic beta-2 receptor agonists
bronchodilator agents
anti-inflammatory agents
insurance, health, reimbursement
asthma
adult
adolescent
treatment outcome
randomized controlled trials as topic
ethanolamines
androstadienes
---
http://www.cochrane.org/fr/CD007695
2013
false
United Kingdom
France
French
Asthma chronic
Formoterol Fumarate
Salmeterol Xinafoate
meta-analysis
asthma
chronic disease
anti-asthmatic agents
bronchodilator agents
adrenergic beta-2 receptor agonists
french abstract
---
http://www.cochrane.org/fr/CD007085
2013
false
true
false
France
United Kingdom
treatment outcome
Formoterol Fumarate
budesonide
review of literature
french abstract
asthma
child
adult
Childhood asthma (disorder)
---
http://www.cochrane.org/fr/CD008418
2013
false
true
false
France
United Kingdom
asthma
Formoterol Fumarate
adrenergic beta-agonists
review of literature
french abstract
child
adult
Childhood asthma (disorder)
---
http://www.cochrane.org/fr/CD006923
2013
false
United Kingdom
France
French
Asthma chronic
Formoterol Fumarate
meta-analysis
asthma
chronic disease
adrenergic alpha-2 receptor agonists
treatment outcome
bronchodilator agents
french abstract
---
http://www.cochrane.org/fr/CD009769
2013
false
United Kingdom
France
French
review of literature
pulmonary disease, chronic obstructive
treatment outcome
beclomethasone
glucocorticoids
comparative study
french abstract
bronchodilator agents
administration, inhalation
adrenergic beta-2 receptor agonists
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Formoterol Fumarate
---
http://www.has-sante.fr/portail/jcms/c_1231629/asmelor-novolizer
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/asmelor_novolizer_29022012_ct11713.pdf
http://www.has-sante.fr/portail/jcms/c_810812/asmelor-novolizer
2012
false
France
French
corticosteroid therapy
Formoterol Fumarate
administration, inhalation
bronchodilator agents
formoterol
insurance, health, reimbursement
adrenergic beta-2 receptor agonists
asthma
obstruction of bronchus
pulmonary disease, chronic obstructive
drug therapy, combination
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1234507/foradil
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/foradil_29022012_avis_ct10378.pdf
http://www.has-sante.fr/portail/jcms/c_455414/foradil
2012
false
France
French
corticosteroid therapy
Formoterol Fumarate
administration, inhalation
bronchodilator agents
formoterol
insurance, health, reimbursement
asthma
lung diseases, obstructive
drug therapy, combination
asthma, exercise-induced
adrenergic beta-2 receptor agonists
dry powder inhalers
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1234495/atimos-formoair
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/atimos_formoair_29022012_avis_ct9735_2012-04-16_10-50-36_843.pdf
2012
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Formoterol Fumarate
formoterol
administration, inhalation
insurance, health, reimbursement
treatment outcome
adrenergic beta-2 receptor agonists
bronchodilator agents
asthma
pulmonary disease, chronic obstructive
drug therapy, combination
---
http://www.lecrat.eu/?s=Formot%C3%A9rol
2008
false
France
French
Formoterol Fumarate
bronchodilator agents
pregnancy
adrenergic beta-agonists
breast feeding
formoterol
drug information
---
http://www.has-sante.fr/portail/display.jsp?id=c_642810
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-5232_formoair_.pdf
2008
false
France
French
Formoterol Fumarate
evaluation of the transparency committee
insurance, health, reimbursement
pulmonary disease, chronic obstructive
treatment outcome
administration, inhalation
formoterol
bronchodilator agents
adrenergic beta-2 receptor agonists
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-5085_innovair_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_614859
2007
false
France
French
formoterol and beclometasone
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Formoterol Fumarate
beclomethasone
drug combinations
bronchodilator agents
glucocorticoids
anti-inflammatory agents
insurance, health, reimbursement
administration, inhalation
asthma
treatment outcome
adrenergic beta-2 receptor agonists
Beclomethasone Dipropionate
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_614872
2007
false
France
French
evaluation of the transparency committee
formoterol and beclometasone
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Formoterol Fumarate
drug combinations
bronchodilator agents
beclomethasone
glucocorticoids
insurance, health, reimbursement
asthma
adrenergic beta-2 receptor agonists
treatment outcome
Beclomethasone Dipropionate
administration, inhalation
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032473.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400894
2006
false
France
French
Formoterol Fumarate
insurance, health, reimbursement
bronchodilator agents
formoterol
adrenergic beta-agonists
drug therapy, combination
asthma
treatment outcome
administration, inhalation
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1073290/atimos
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-07/atimos_-_ct-2244.pdf
2006
false
France
French
evaluation of the transparency committee
guidelines for drug use
corticosteroid therapy
Formoterol Fumarate
insurance, health, reimbursement
administration, inhalation
formoterol
adrenergic beta-2 receptor agonists
bronchodilator agents
drug therapy, combination
asthma
---
